When was Eyedaptic founded?

Eyedaptic was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is Eyedaptic located?

Eyedaptic is headquartered in Laguna Niguel, United States. It is registered at 23421 South Pointe Drive, Laguna Hills, CA.

Who is the current CEO of Eyedaptic?

Jay Cormier of Eyedaptic. They have also founded 1 company.

How many employees does Eyedaptic have?

As of May 31, 2026, the latest employee count at Eyedaptic is 10.

Is Eyedaptic a funded company?

Eyedaptic is a funded company, having raised a total of $1.47M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 30, 2017.

How much is Eyedaptic worth?

The latest valuation of Eyedaptic is $***** as of Oct 06, 2022.

When was the latest funding round of Eyedaptic?

Eyedaptic's latest funding was a $***** Seed round on Feb 26, 2021, with participation from 0 investor.

What is the annual revenue of Eyedaptic?

Annual revenue of Eyedaptic is less than $1M as on Dec 31, 2023

Where does Eyedaptic rank among its competitors?

Eyedaptic ranks 2nd amongst 44 active competitors, of which 13 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Second Sight, which secured $1.1M in Jul, 2022.

Who are the top competitors of Eyedaptic?

Eyedaptic's top competitors include Neurotech, RecensMedical and Second Sight. Among them, Second Sight secured the most recent funding round in July, 2022.

Eyedaptic - 2026 Company Profile, Team, Funding & Competitors

Company Details

Smart glasses enhancing vision for macular degeneration and low vision. They are dedicated to enhancing vision and revitalizing life for individuals with low vision. They offer smart glasses designed to make everyday tasks easier and improve the quality of life for those with Age-Related Macular Degeneration, Diabetic Retinopathy, and other central vision loss conditions. Their premier solution optimizes remaining vision with revolutionary, patented software. They leverage augmented reality (AR) and artificial intelligence (AI) technology to develop software-driven smart glasses. They also offer a Generative AI Visual Assistant, providing visual assistance. Their products aim to improve the vision of those suffering from retinal disorders. They are a B2C company with a social impact business model.

Website: eyedaptic.com
Registered Address: 23421 South Pointe Drive, Laguna Hills, CA

Key Metrics

Founded Year

2016

Location

Laguna Niguel, United States

Stage

Seed

Total Funding

$1.47M in 4 rounds

Latest Funding Round

Seed, Feb 26, 2021, $*****

Post Money Valuation

$***** as on Oct 06, 2022

Investors

Crescite Ventures & 3 more

Ranked

2^nd among 44 active competitors

Annual Revenue

$0 - $1M as on Dec 31, 2023

Employee Count

10 as on May 31, 2026

Similar Companies

Neurotech & 50 more

View Eyedaptic's full profile

Eyedaptic is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Eyedaptic, Inc. CIN: 0001713933 , United States, Active	Sep 12, 2016	$0 - $1M (As on Dec 31, 2023)	3 (As on Dec 31, 2023)	-
Eyedaptic, Inc. CIN: 814069920 , United States, Active		$0 - $1M (As on Dec 31, 2023)	-	-

Eyedaptic has raised a total funding of $1.47M over 4 rounds. Its first funding round was on Aug 30, 2017. Eyedaptic has 4 institutional investors.

Here is the list of recent funding rounds of Eyedaptic:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 26, 2021	9468695	Seed	3514760	3575909	7055149	8517147
Dec 19, 2019	4268343	Seed	3906783	3312555	2353395	7458869
May 15, 2018	3987302	Seed	2726671	5504964	3478288	9600094

Access funding benchmarks and valuations. Sign up today!

View details of Eyedaptic's funding rounds and investors

The founders of Eyedaptic is Jay Cormier. Jay Cormier is the CEO of Eyedaptic.

Here are the details of Eyedaptic's key team members:

Jay Cormier: CEO & Founder of Eyedaptic.

View details of Eyedaptic's Founder profiles and Board Members

Eyedaptic's employee count trend

Eyedaptic has 10 employees as of May 26. Here is Eyedaptic's employee count trend over the years:

Uncover Eyedaptic's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Eyedaptic include Neurotech, RecensMedical and Second Sight. Here is the list of Top 10 competitors of Eyedaptic, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Neurotech 2000, Cumberland (United States), Series B	Developer of a cell-based delivery device for the treatment of eye diseases	$53.3M	Apax, Atlas Venture & 12 others	57/100
2nd	Eyedaptic 2016, Laguna Niguel (United States), Seed	Smart glasses enhancing vision for macular degeneration and low vision	$1.47M	Crescite Ventures, New York Angels & 2 others	52/100
3rd	RecensMedical 2016, Ulsan (South Korea), Public	Developer of an anesthetic medical device for retinal diseases	-	Intops Investment, SOORIM venture capital ... & 3 others	48/100
4th	Second Sight 2000, Los Angeles (United States), Public	Provider of an implantable visual prosthetic for blind individuals	$36.9M	Versant Ventures, MDB Capital & 2 others	47/100
5th	Pixium Vision 2011, Paris (France), Public	Provider of bionic vision restoration systems	$32.5M	Sofinnova Partners, Lifeblood Capital & 11 others	46/100
6th	iScience Interventional 1999, Menlo Park (United States), Acquired	Innovative medical device company focused on interventional solutions	$36.7M	Medtronic, Affinity Capital Management & 11 others	44/100
7th	Cerevast 2009, Bothell (United States), Series C	Medical device company developing innovative ultrasound and microsphere therapies	$46.9M	Swiftsure, Haiyin Capital	38/100
8th	Pykus Therapeutics 2016, Boston (United States), Seed	Develops a dissolvable intraocular device for use during retinal surgery	$2.49M	Hongsen Investment, Astellas Venture Management ... & 5 others	38/100
9th	Medical Instrument Development Laboratories 1981, San Leandro (United States), Acquired	Innovating ophthalmic surgical devices to prevent blindness and improve global vision	$50M	Orbimed, SBCVC & 3 others	37/100
10th	2C Tech Corporation 2010, Irvine (United States), Series B	Provider of nanotech-based medical devices to treat retinal disorders	$15.5M	Exsight Ventures, HOYA & 2 others	36/100